Life Extension Stocks List
|LIFS||D||Life Stem Genetics Inc||0.00|
|XENO||D||Xeno Transplants Corp||-3.81|
|AATP||B||Agape Atp Corp||0.00|
|WDGJY||B||John Wood Group Plc ADR||0.00|
|STUO||D||STI Group Inc||0.00|
View all Life Extension related ETFs...
|2021-05-17||XENO||20 DMA Resistance||Bearish|
|2021-05-17||XENO||50 DMA Resistance||Bearish|
|2021-05-17||XENO||Shooting Star Candlestick||Bearish|
|2021-05-17||XENO||Doji - Bullish?||Reversal|
|2021-05-17||XENO||Doji - Bearish?||Reversal|
|2021-05-17||XENO||Reversal New Lows Setup||Bearish Swing Setup|
Life extension is the idea of extending the human lifespan, either modestly – through improvements in medicine – or dramatically by increasing the maximum lifespan beyond its generally settled limit of 125 years. The ability to achieve such dramatic changes, however, does not currently exist.Some researchers in this area, and "life extensionists", "immortalists" or "longevists" (those who wish to achieve longer lives themselves), believe that future breakthroughs in tissue rejuvenation, stem cells, regenerative medicine, molecular repair, gene therapy, pharmaceuticals, and organ replacement (such as with artificial organs or xenotransplantations) will eventually enable humans to have indefinite lifespans (agerasia) through complete rejuvenation to a healthy youthful condition. The ethical ramifications, if life extension becomes a possibility, are debated by bioethicists.
The sale of purported anti-aging products such as supplements and hormone replacement is a lucrative global industry. For example, the industry that promotes the use of hormones as a treatment for consumers to slow or reverse the aging process in the US market generated about $50 billion of revenue a year in 2009. The use of such products has not been proven to be effective or safe.